Bayer expands Nubeqa® in India as a treatment option without chemotherapy for men with metastatic hormone sensitive prostate cancer sensitive prostate cancer
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year. Around 40% of the cases are diagnosed in the metastatic stage . Bayer announced that its cancer drug, Nubeqa® has lately received approval in India for an expanded indication, offering clinicians access to a non-chemotherapy treatment option for […]






Leave a Reply